Vyne Therapeutics Inc.
13F holders, Q1 2025 (March 31)1holders
0new positions
0sold out
$1.58avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Vyne Therapeutics Inc. in their 13F filings, unchanged from Q4 2024. 0 opened new positions and 0 sold out. The largest holder was Staley Capital Advisers Inc. ($81K).
- Company
- Vyne Therapeutics Inc.
- CUSIP
- 92941V209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 15,000 shares bought, net +15,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Staley Capital Advisers Inc. | 0.00% | Add +41.1% | 51,472 | $81K |
"% of holder's portfolio" is VYNE THERAPEUTICS INC's weight in each manager's 13F, not the share of Vyne Therapeutics Inc. the manager owns.